Table 2 Indicators at baseline and during follow up periods, including worst case-scenarios
| Â | Intake survey | Intake survey among group with follow-up | One-month | One-month worst-casea | One-month worst-caseb | Two- month | Two-month worst-casea | Two-month worst-caseb | Six-month | Six-month worst -casea | Six-month worst -caseb | Twelve-month | Twelve-month worst-casea | Twelve-month worst-caseb |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Number of respondents on OAT (%) | 0/84 (0%) | 0/60 (0%) | 12/31 (39%) | 12/60 (20%) | 12/84 (14%) | 12/32 (38%) | 12/60 (20%) | 12/84 (14%) | 16/33 (48%) | 16/60 (27%) | 16/84 (19%) | 19/34 (56%) | 19/60 (32%) | 19/84 (23%) |
Number of respondents engaged in care (%) | 18/81 (22%) | 13/58 (22%) | 20/31 (66%) | 20/58 (34%) | 20/81 (25%) | 26/32 (81%) | 26/58 (45%) | 26/81 (32%) | 24/33 (73%) | 24/58 (41%) | 24/81 (30%) | 25/34 (74%) | 25/58 (43%) | 25/81 (31%) |
Number of respondents with fixed housing (%) | 27/84 (32%) | 24/60 (40%) | 16/31 (52%) | Â 16/60 (27%) | 16/84 (19%) | 18/32 (56%) | 18/60 (30%) | 18/84 (21%) | 16/33 (48%) | 16/60 (27%) | 16/84 (19%) | 20/34 (59%) | 20/60 (33%) | 20/84 (24%) |
Report no illicit opioid use in last 7Â days (%) | 0/81 (0%) | 0/58 (0%) | 4/31 (13%) | 4/58 (7%) | 4/81 (5%) | 3/32 (9%) | 3/58 (5%) | 3/81 (4%) | 5/33 (15%) | 5/58 (9%) | 5/81 (6%) | 5/34 (15%) | 5/58 (9%) | 5/81 (6%) |
Median days of illicit opioid use in last 7 days | 7 [IQR 7–7] (N =  81) | 7 [IQR 7–7] (N = 58) | 7 [IQR 5.5–7] (N = 31) | N/A | N/A | 7 [IQR 6.75–7] (N = 32) | N/A | N/A | 7 [IQR 2–7] (N = 33) | N/A | N/A | 7 [IQR 4.25–7] (N = 34) | N/A | N/A |
Median Euroqol score | 50 [IQR 30–70] (N =  83) | 50 [IQR 30–70] (N = 59) | 60 [IQR 40–65] (N = 30) | N/A | N/A | 50 [IQR 40–70] (N = 32) | N/A | N/A | 62.5 [IQR 50–75] (N = 32) | N/A | N/A | 60 [IQR 45–75] (N = 33) | N/A | N/A |